RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $904M
1-Year Est. Return 12.31%
This Quarter Est. Return
1 Year Est. Return
+12.31%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$904M
AUM Growth
+$113M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
103
New
Increased
Reduced
Closed

Top Buys

1
+$14.1M
2
+$13.9M
3
+$11.1M
4
AXSM icon
Axsome Therapeutics
AXSM
+$9.96M
5
TMO icon
Thermo Fisher Scientific
TMO
+$9.17M

Top Sells

1
+$15.8M
2
+$13.9M
3
+$11.4M
4
VRNA
Verona Pharma
VRNA
+$10.1M
5
GILD icon
Gilead Sciences
GILD
+$9.77M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LIVN icon
76
LivaNova
LIVN
$3.45B
$2.78M 0.31%
53,000
ANNX icon
77
Annexon
ANNX
$1.01B
$2.51M 0.28%
823,000
+363,000
UHS icon
78
Universal Health Services
UHS
$12.8B
$2.45M 0.27%
12,000
-14,000
JANX icon
79
Janux Therapeutics
JANX
$891M
$2.45M 0.27%
100,127
+45,000
RLAY icon
80
Relay Therapeutics
RLAY
$1.29B
$2.4M 0.27%
460,000
IOVA icon
81
Iovance Biotherapeutics
IOVA
$1.05B
$2.38M 0.26%
1,097,827
+450,000
OCUL icon
82
Ocular Therapeutix
OCUL
$2.19B
$2.36M 0.26%
+202,000
KRYS icon
83
Krystal Biotech
KRYS
$8.16B
$2.07M 0.23%
11,750
-1,000
XNCR icon
84
Xencor
XNCR
$913M
$1.94M 0.22%
165,750
BTSG icon
85
BrightSpring Health Services
BTSG
$7.15B
$1.77M 0.2%
+60,000
MLTX icon
86
MoonLake Immunotherapeutics
MLTX
$1.12B
$1.48M 0.16%
207,000
+162,000
DNLI icon
87
Denali Therapeutics
DNLI
$3.16B
$1.45M 0.16%
100,000
STVN icon
88
Stevanato
STVN
$4.71B
$1.31M 0.15%
+51,000
IRTC icon
89
iRhythm Holdings
IRTC
$5.17B
$1.2M 0.13%
+7,000
IMCR icon
90
Immunocore
IMCR
$1.77B
$1.03M 0.11%
28,278
TECH icon
91
Bio-Techne
TECH
$10.6B
$834K 0.09%
15,000
ATEC icon
92
Alphatec Holdings
ATEC
$2.32B
$262K 0.03%
+18,000
ALC icon
93
Alcon
ALC
$39.4B
– –
-68,000
DXCM icon
94
DexCom
DXCM
$28.4B
– –
-159,500
HCA icon
95
HCA Healthcare
HCA
$107B
– –
-29,778
INMB icon
96
INmune Bio
INMB
$45.2M
– –
-178,284
MOH icon
97
Molina Healthcare
MOH
$10.4B
– –
-22,200
OSCR icon
98
Oscar Health
OSCR
$4.52B
– –
-312,092
RGEN icon
99
Repligen
RGEN
$9.14B
– –
-19,500
SMMT icon
100
Summit Therapeutics
SMMT
$12.3B
– –
-78,000
1 2 3
4
5